Mylan Completes Acquisition of Generics Business of Merck KGaA
Pittsburgh (ots/PRNewswire) - Mylan (NYSE: MYL) announced today that it has completed its acquisition of Merck KGaA's generics business ("Merck Generics") to become one of the largest quality generics and specialty pharmaceuticals companies in the world. Mylan and Merck KGaA initially announced the signing of a definitive agreement under which Mylan would acquire Merck Generics for EUR 4.9 billion (US$6.8 billion) ...